Campbell Shane Alden 4

4 · WEST PHARMACEUTICAL SERVICES INC · Filed May 14, 2025

Insider Transaction Report

Form 4
Period: 2025-05-12
Campbell Shane Alden
SVP, Proprietary Segment
Transactions
  • Award

    Stock Options (Right to Buy)

    2025-05-12$219.46/sh+2,852$625,9002,852 total
    Exercise: $219.46From: 2026-05-12Exp: 2035-05-12Stock Options (Right to Buy) (2,852 underlying)
  • Award

    Rst. Stock Unit

    2025-05-12+1,1821,182 total
    Exercise: $0.00Common Stock (1,182 underlying)
  • Award

    Rst. Stock Unit

    2025-05-12+1,8911,891 total
    Exercise: $0.00Common Stock (1,891 underlying)
Footnotes (1)
  • [F1]This award vests in four equal annual installments beginning on May 12, 2026.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POA